challenging status quo ON
Epidemic
Response & Innovation in Africa!
News about our work
01
A coalition from global south to effectively respond to epidemics...
Vision:
Our vision is to effectively respond to epidemics through pathogen genomics surveillance to enhance biomedical discovery, improving the treatment, diagnosis and prevention of human disease and generating economic opportunities for Africa.
We use our expertise in genomics to identify new variants of pathogens and advance basic and translational science to improve prevention, treatment and vaccines to human disease in Africa.
02
Genomics & Digital Biology
03
Genotype-to-phenotype
The Institute will have access to advanced P3+ biosafety level laboratories and animal models to determine pathogens’ phenotypes.
Vaccine Evaluation
In collaboration with Prof. Alex Sigal group, we evaluate the effectiveness of vaccines on the neutralization of variants.
Antimicrobial Resistance
We also focus on the identification of antimicrobial resistance and the evaluation of the most appropriate diagnostics and therapies for resistance pathogens.
Recent Publications
Big Data, Epidemiology & AI
CERI has a scientific team that specializes in epidemiology, big data, computational intelligence, and bioinformatics. These analytical skills are necessary to understand how pathogen genetic variation affects the transmission, diagnosis, treatment, and vaccination. We are able to analyze large datasets and provide information on how to guide public health response.
We Can Help Preparing to
Future Epidemics
Now
We are building a team at the School for Data Science and Computational Intelligence to continue use advanced algorithms to identify the first signs of epidemics in Africa..
We have a Hamilton BIOS, which is a fully automated -80C biorepository that can store over 3 million samples. It also allows quick access to samples for genotyping and phenotyping.